{"id":405422,"date":"2025-11-26T07:11:16","date_gmt":"2025-11-26T07:11:16","guid":{"rendered":"https:\/\/www.europesays.com\/us\/405422\/"},"modified":"2025-11-26T07:11:16","modified_gmt":"2025-11-26T07:11:16","slug":"u-s-negotiates-lower-prices-for-ozempic-and-14-other-drugs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/405422\/","title":{"rendered":"U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs"},"content":{"rendered":"

The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic<\/a>, widening an effort to rein in drug costs<\/a>.<\/p>\n

The new prices, which will take effect in 2027, shave 38% to 85% off the list prices for drugs for diseases including asthma, cancer and diabetes. The reductions are estimated to save Medicare, the health-insurance program<\/a> for the elderly, $12 billion.<\/p>\n

Copyright \u00a92025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening…\n","protected":false},"author":3,"featured_media":405423,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[235,19451,190830,191371,191378,190835,12024,60,57,191365,190844,190832,190831,191369,126181,191373,191379,210,191367,1142,191368,191370,190843,7337,10273,27531,191384,191383,191386,191385,191381,191382,3221,135,191372,88900,24788,1060,29591,191376,191366,587,9412,191377,191375,30898,191380,152,3234,190263,80,190834,6769,5660,114399,191374,67,132,68,190235],"class_list":{"0":"post-405422","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-cancer","9":"tag-corporate","10":"tag-corporate-industrial-news","11":"tag-diabetes-drugs","12":"tag-dknovo-b","13":"tag-domestic-politics","14":"tag-economic-news","15":"tag-financial-services","16":"tag-general-news","17":"tag-gfx-contrib","18":"tag-government-budget","19":"tag-government-budget-taxation","20":"tag-government-finance","21":"tag-government-sponsored-health-insurance","22":"tag-gsk","23":"tag-gsk-ln","24":"tag-gsks","25":"tag-health","26":"tag-health-medical-insurance","27":"tag-healthcare","28":"tag-healthcare-life-sciences","29":"tag-hormone-products","30":"tag-industrial-news","31":"tag-insurance","32":"tag-international-relations","33":"tag-life-sciences","34":"tag-linki1-wp-wsj-0003121789","35":"tag-linki2-wp-wsj-0003121789","36":"tag-linki3-wp-wsj-0003121789","37":"tag-linki4-wp-wsj-0003121789","38":"tag-linki5-wp-wsj-0003121789","39":"tag-linki6-wp-wsj-0003121789","40":"tag-marketing","41":"tag-markets","42":"tag-markets-marketing","43":"tag-medical-conditions","44":"tag-medical-insurance","45":"tag-medication","46":"tag-merck","47":"tag-mrk","48":"tag-non-life-insurance","49":"tag-north-america","50":"tag-novo-nordisk","51":"tag-novo-b-ko","52":"tag-pfe","53":"tag-pfizer","54":"tag-pfizers","55":"tag-pharmaceuticals","56":"tag-political","57":"tag-political-general-news","58":"tag-politics","59":"tag-politics-international-relations","60":"tag-prices","61":"tag-synd","62":"tag-taxation","63":"tag-ukgsk","64":"tag-united-states","65":"tag-unitedstates","66":"tag-us","67":"tag-wsj-pro-wsj-com"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/405422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=405422"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/405422\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/405423"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=405422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=405422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=405422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}